Paperpal Prime Logo

ANNALS OF THE AMERICAN THORACIC SOCIETY : Impact Factor & More

eISSN: 2325-6621pISSN: 1546-3222

Aims and Scope of ANNALS OF THE AMERICAN THORACIC SOCIETY

The Annals of the American Thoracic Society is an official medical journal of the American Thoracic Society (ATS). It publishes original clinical and epidemiological research in the fields of pulmonology, critical care medicine, and sleep medicine. Known colloquially as the "White Journal", the Annals of the American Thoracic Society is one of four journals published by the American Thoracic Society, along with the American Journal of Respiratory and Critical Care Medicine ("Blue Journal"), American Journal of Respiratory Cell and Molecular Biology ("Red Journal"), and ATS Scholar. Less

Key Metrics

Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.86 5-Year SI
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ANNALS OF THE AMERICAN THORACIC SOCIETY

ANNALS OF THE AMERICAN THORACIC SOCIETY Journal Specifications

Overview
Publisher AMER THORACIC SOC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in ANNALS OF THE AMERICAN THORACIC SOCIETY ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ANNALS OF THE AMERICAN THORACIC SOCIETY

Reply to: 'Location, Location, Location: Expanding Access to In-person Pulmonary Rehabilitation through Primary Care.'
  • 8 Aug 2026
  • Annals of the American Thoracic Society
Breathing Easier with Weight-Loss Drugs? Respiratory Safety Signals in Weight Loss Drug Trials.
  • 7 Aug 2026
  • Annals of the American Thoracic Society
Breathlessness in Fibrotic Hypersensitivity Pneumonitis: From Symptom to Signal.
  • 7 Aug 2026
  • Annals of the American Thoracic Society
Randomized clinical trial of self-management of sedative therapy by mechanically ventilated patients.
  • 5 Aug 2026
  • Annals of the American Thoracic Society
Pulmonary Outcomes in People with Cystic Fibrosis who Stop Chronic Daily Therapies: The HERO-2 Study.
  • 5 Aug 2026
  • Annals of the American Thoracic Society
Within-Person Sweat Chloride Variability in People with Cystic Fibrosis Measured via Wearable Microfluidic Sticker.
  • 4 Aug 2026
  • Annals of the American Thoracic Society
Reply to: 'Location, Location, Location: Expanding Access to In-person Pulmonary Rehabilitation through Primary Care.'
  • 8 Aug 2026
  • Annals of the American Thoracic Society
Breathing Easier with Weight-Loss Drugs? Respiratory Safety Signals in Weight Loss Drug Trials.
  • 7 Aug 2026
  • Annals of the American Thoracic Society
Breathlessness in Fibrotic Hypersensitivity Pneumonitis: From Symptom to Signal.
  • 7 Aug 2026
  • Annals of the American Thoracic Society
Randomized clinical trial of self-management of sedative therapy by mechanically ventilated patients.
  • 5 Aug 2026
  • Annals of the American Thoracic Society
Pulmonary Outcomes in People with Cystic Fibrosis who Stop Chronic Daily Therapies: The HERO-2 Study.
  • 5 Aug 2026
  • Annals of the American Thoracic Society
Within-Person Sweat Chloride Variability in People with Cystic Fibrosis Measured via Wearable Microfluidic Sticker.
  • 4 Aug 2026
  • Annals of the American Thoracic Society

FAQs on ANNALS OF THE AMERICAN THORACIC SOCIETY